Piper Jaffray maintained an Overweight rating on Illumina (NASDAQ: ILMN), and cut the price target to $220.00 (from $230.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Illumina (ILMN) PT Slashed to $137 at Goldman SachsOctober 6, 2015 9:28 AM Canaccord Genuity Reiterates Buy on Illumina (ILMN) Following 3Q15 Preliminary Results October 6, 2015 8:37 AM Illumina (ILMN) PT Lowered to $200 at UBS; Says May Be Time to BuyOctober 6, 2015 7:44 AM BTIG Downgrades Illumina (ILMN) to NeutralOctober 6, 2015 6:53 AM Illumina (ILMN) Announces Expanded HiSeq X Sequencing System Rights for non-Human SpeciesOctober 6, 2015 6:31 AM Illumina Expands Use of HiSeq X™ Sequencing System to Include Non-Human SpeciesOctober 6, 2015 6:30 AM Mizuho Securities Downgrades Illumina (ILMN) to NeutralOctober 6, 2015 6:26 AM Leerink Trims PT on Illumina (ILMN) to $185 Following Negative Q3 PreannouncementOctober 6, 2015 6:20 AM After Hours Stocks Movers 10/05: (STRZA) (RGLS) (LGF) Higher; (EXAS) (ILMN) (TCS) (more...)October 5, 2015 6:33 PM Market Wrap: Twitter Affirms Dorsey as CEO; DuPont CEO Kullman to Step Down; Peltz Gets Active on GEOctober 5, 2015 5:26 PM Illumina (ILMN) Prelim. Q3 Revenue Misses Expectations; Guides Q4 Revenue Below ConsensusOctober 5, 2015 4:07 PM Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2015October 5, 2015 4:05 PM